BMC public health · 2026
Ten-year cardiometabolic progression and health-related quality of life in individuals with isolated abdominal obesity.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Nazarova Lazzat, Nuskabayeva Gulnaz, Assanova Galiya, Tilemissov Magzhan, Izzatullayeva Gulmira, Aidarbekova Dilbar, Sadykova Karlygash, Saruarov Yerbolat
Аннотация
BACKGROUND: Increasing evidence suggests that abdominal fat distribution is a greater predictor of metabolic risk (MetS) than BMI. This study aimed to evaluate the 10-year cardiometabolic consequences of isolated abdominal obesity (IAO) and its association with MetS and health-related quality of life (HRQoL).
METHODS: This longitudinal cohort study included 552 adults from the Turkestan region of Kazakhstan who underwent baseline assessment in 2014 and follow-up examination in 2024. Anthropometric, clinical, and laboratory parameters were measured, and the HRQoL was assessed by the SF-36 questionnaire.
RESULTS: At baseline, 403 participants (73%) had IAO, and 149 (27%) did not. Participants with IAO were older (45 vs. 37 years, p < 0.001) and more frequently female (79%). They had higher body weight, waist circumference, BMI, blood pressure, and unfavorable metabolic parameters, including higher cholesterol, triglyceride, and glucose levels (all p < 0.05). Metabolic syndrome was more prevalent in the IAO group (30% vs. 1%, p < 0.001). After 10 years, IAO was observed in 472 participants: 97% of those with IAO at baseline remained obese, compared with 54% of those without baseline obesity who developed it (p < 0.001). Baseline IAO independently predicted incident metabolic syndrome (ORadj = 1.34; p = 0.041). Participants with persistent IAO had lower HRQoL scores in physical functioning, general health, and mental health than individuals without IAO (p < 0.05).
CONCLUSIONS: Persistent isolated abdominal obesity was associated with lower health-related quality of life and independently predicted metabolic syndrome over the 10-year follow-up period. These results highlight the importance of assessing abdominal adiposity in clinical practice.
METHODS: This longitudinal cohort study included 552 adults from the Turkestan region of Kazakhstan who underwent baseline assessment in 2014 and follow-up examination in 2024. Anthropometric, clinical, and laboratory parameters were measured, and the HRQoL was assessed by the SF-36 questionnaire.
RESULTS: At baseline, 403 participants (73%) had IAO, and 149 (27%) did not. Participants with IAO were older (45 vs. 37 years, p < 0.001) and more frequently female (79%). They had higher body weight, waist circumference, BMI, blood pressure, and unfavorable metabolic parameters, including higher cholesterol, triglyceride, and glucose levels (all p < 0.05). Metabolic syndrome was more prevalent in the IAO group (30% vs. 1%, p < 0.001). After 10 years, IAO was observed in 472 participants: 97% of those with IAO at baseline remained obese, compared with 54% of those without baseline obesity who developed it (p < 0.001). Baseline IAO independently predicted incident metabolic syndrome (ORadj = 1.34; p = 0.041). Participants with persistent IAO had lower HRQoL scores in physical functioning, general health, and mental health than individuals without IAO (p < 0.05).
CONCLUSIONS: Persistent isolated abdominal obesity was associated with lower health-related quality of life and independently predicted metabolic syndrome over the 10-year follow-up period. These results highlight the importance of assessing abdominal adiposity in clinical practice.